HemoGenix® announced today that results from its HALO® family of cell therapy assays, which measure stem cell quality and potency of umbilical cord blood units prior to transplantation, can now be uploaded to the National Marrow Donor Program EmTrax UCB database.
News Source
News Source
No comments:
Post a Comment